© 2025 - 2026
The Life Science Feed. All rights reserved.
A digital publication from Grá & Mawi Media Co.
Remibrutinib Resolves Chronic Inducible Urticaria Symptoms
A novel BTK inhibitor, remibrutinib, demonstrated efficacy in resolving symptoms of chronic inducible urticaria in clinical trials.